Sweet syndrome and disseminated Mycobacterium tuberculosis infection

Eur J Dermatol. 2016 Jan-Feb;26(1):99-100. doi: 10.1684/ejd.2015.2711.

Authors

Emmanuel Ledoult¹, Coralie Becquart², Noémie Chanson¹, Vincent Sobanski³, Martine Remy-Jardin⁴, Emmanuel Delaporte², Pierre-Yves Hatron⁵

Affiliations

¹ Department of Internal Medicine.
² Department of Dermatology, Claude-Huriez Hospital, University of Lille, Lille, France, University Lille 2, Lille, France.
³ Department of Internal Medicine,, Department of Thoracic Imaging, Calmette Hospital, Lille, France.
⁴ Department of Thoracic Imaging, Calmette Hospital, Lille, France, University Lille 2, Lille, France.
⁵ Department of Internal Medicine,, University Lille 2, Lille, France.

PMID: 26891891
DOI: 10.1684/ejd.2015.2711

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antitubercular Agents / therapeutic use
Colchicine / therapeutic use
Dermatologic Agents / therapeutic use
Female
Humans
Middle Aged
Sweet Syndrome / complications*
Sweet Syndrome / drug therapy
Tuberculosis, Pulmonary / complications*
Tuberculosis, Pulmonary / diagnosis
Tuberculosis, Pulmonary / drug therapy

Substances

Antitubercular Agents
Dermatologic Agents
Colchicine